On the heels of winning FDA approval for its generic version of the type 2 diabetes drug Prandin, Caraco Pharmaceutical Laboratories announced a big expansion of its Detroit facilities, creating 600 jobs over the next five years and boosting pill production by 40 percent to 5 billion per year.
Majority owned by Sun Pharmaceuticals of India, Caraco now employs 455 people. It considered expanding in the Carolinas instead--both states aggressively wooed the company--but opted to grow in Detroit after Michigan's governor offered tuition-free job training at community colleges and technical schools.
- see the release on the approval
- here's the report from The Detroit Free Press